Naïve B-cell receptors specific for diphtheria, tetanus, pertussis, poliovirus, and Haemophilus influenzae type b epitopes (Naïve BCRs (DTP-IPV-Hib))

Naïve B-cell receptors (BCRs) specific for diphtheria, tetanus, pertussis, poliovirus, and Hib PRP epitopes are membrane-bound immunoglobulins on B lymphocytes that recognize specific pathogen-derived antigens (Janeway et al., Immunobiology, 2001). These receptors are the primary targets for multi-component vaccines such as DTaP-IPV-Hib, which aim to induce protective immunity against Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, Poliovirus, and Haemophilus influenzae type b (CDC, Pink Book, 2021). Upon antigen binding, these BCRs initiate signal transduction through the Ig-alpha and Ig-beta complex, leading to B-cell activation and differentiation into plasma cells and memory B cells (Reth & Wienands, Annual Review of Immunology, 1997). The Hib component specifically targets BCRs recognizing the polyribosylribitol phosphate (PRP) capsular polysaccharide, often conjugated to a protein carrier to enhance T-cell dependent responses (Frasch, Vaccine, 1995). This collective target is central to pediatric immunization strategies, ensuring the development of long-term humoral immunity against multiple life-threatening diseases.

Other names

Antigen-specific B-cell receptorsNaïve B-cell repertoireDTP-IPV-Hib specific BCRsVaccine-responsive B-cell receptors

Vaccine antigens bind to the variable regions of specific naïve B-cell receptors, inducing receptor clustering and activation of intracellular signaling cascades (e.g., Lyn, Syk, and PLC-gamma2). This leads to antigen internalization, processing, and presentation to T-helper cells, resulting in B-cell proliferation, isotype switching, and affinity maturation within germinal centers (Murphy & Weaver, Janeway's Immunobiology, 2016).